ORAMED PHARMACEUTICALS INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Mayer Arie | — | Award / Grant | 6,975 | — | — | 133,109 | Jun 5, 2025 |
| Aghion Daniel | — | Award / Grant | 30,000 | — | — | 68,820 | Jun 5, 2025 |
| Reznick Yehuda | — | Award / Grant | 30,000 | — | — | 60,560 | Jun 5, 2025 |
| Sank Leonard | — | Award / Grant | 6,510 | — | — | 134,531 | Jun 5, 2025 |
| Shapiro Benjamin | — | Award / Grant | 30,000 | — | — | 85,070 | Jun 5, 2025 |
| Kidron Miriam | Chief Scientific Officer | Award / Grant | 74,000 | — | — | 1,074,666 | Feb 11, 2025 |
| Hexter Joshua | COO & CBO | Award / Grant | 33,334 | — | — | 833,167 | Feb 11, 2025 |
| KIDRON NADAV | President and CEO | Award / Grant | 186,000 | — | — | 2,586,598 | Feb 11, 2025 |
| Gabay Avraham | Chief Financial Officer | Award / Grant | 42,000 | — | — | 434,040 | Feb 11, 2025 |
| Kidron Miriam | Chief Scientific Officer | Award / Grant | 207,000 | — | — | 1,000,666 | Jan 2, 2025 |
| KIDRON NADAV | President and CEO | Award / Grant | 433,500 | — | — | 2,259,598 | Jan 2, 2025 |
| Gabay Avraham | Chief Financial Officer | Award / Grant | 188,000 | — | — | 358,040 | Jan 2, 2025 |
| Hexter Joshua | COO & CBO | Award / Grant | 194,500 | — | — | 706,333 | Jan 2, 2025 |
| Gabay Avraham | Chief Financial Officer | Award / Grant | 30,000 | — | — | 170,040 | Nov 7, 2024 |
| KIDRON NADAV | President and CEO | Award / Grant | 45,000 | — | — | 1,826,098 | Nov 7, 2024 |
| Kidron Miriam | Chief Scientific Officer | Award / Grant | 30,000 | — | — | 793,666 | Nov 7, 2024 |
| Hexter Joshua | COO & CBO | Award / Grant | 30,000 | — | — | 511,833 | Nov 7, 2024 |
| Gabay Avraham | Chief Financial Officer | Award / Grant | 140,040 | — | — | — | Jun 21, 2024 |
| Reznick Yehuda | — | Award / Grant | 760 | — | — | 30,560 | Jun 6, 2024 |
| Reznick Yehuda | — | Award / Grant | 29,800 | — | — | 29,800 | Apr 17, 2024 |
| Aghion Daniel | — | Award / Grant | 3,750 | — | — | 38,820 | Jan 30, 2024 |
| Kidron Miriam | Chief Scientific Officer | Award / Grant | 295,500 | — | — | 763,666 | Jan 4, 2024 |
| KIDRON NADAV | President and CEO | Award / Grant | 329,000 | — | — | 1,781,098 | Jan 4, 2024 |
| Hexter Joshua | COO & CBO | Award / Grant | 180,500 | — | — | 481,833 | Jan 4, 2024 |
| Silberman David | Chief Financial Officer | Award / Grant | 136,500 | — | — | 366,500 | Jan 4, 2024 |
| Sank Leonard | — | Award / Grant | 9,325 | — | — | 98,021 | Jan 4, 2024 |
| Rozov Yadin | — | Award / Grant | 30,000 | — | — | 146,500 | Jan 4, 2024 |
| Mayer Arie | — | Award / Grant | 30,000 | — | — | 86,809 | Jan 4, 2024 |
| Aghion Daniel | — | Award / Grant | 5,070 | — | — | 35,070 | Jan 4, 2024 |
| Shapiro Benjamin | — | Award / Grant | 30,000 | — | — | 50,000 | Jan 4, 2024 |
| KIDRON NADAV | President and CEO | Award / Grant | 120,000 | — | — | 1,452,098 | May 26, 2023 |
| Derovan Netanel | Chief Legal Officer | Award / Grant | 20,500 | — | — | 149,500 | May 26, 2023 |
| Kidron Miriam | Chief Scientific Officer | Award / Grant | 53,500 | — | — | 468,166 | May 26, 2023 |
| Hexter Joshua | COO & CBO | Award / Grant | 27,000 | — | — | 301,333 | May 26, 2023 |
| Silberman David | Chief Financial Officer | Award / Grant | 24,500 | — | — | 230,000 | May 26, 2023 |
| Shapiro Benjamin | — | Award / Grant | 20,000 | — | — | 20,000 | May 1, 2023 |
| Sank Leonard | — | Award / Grant | 30,000 | — | — | 58,696 | Apr 17, 2023 |
| Derovan Netanel | Chief Legal Officer | Award / Grant | 81,000 | — | — | 129,000 | Apr 17, 2023 |
| Hexter Joshua | COO & CBO | Award / Grant | 108,000 | — | — | 274,333 | Apr 17, 2023 |
| KIDRON NADAV | President and CEO | Award / Grant | 279,000 | — | — | 1,332,098 | Apr 17, 2023 |
| Rozov Yadin | — | Award / Grant | 30,000 | — | — | 116,500 | Apr 17, 2023 |
| Kidron Miriam | Chief Scientific Officer | Award / Grant | 213,000 | — | — | 414,666 | Apr 17, 2023 |
| Silberman David | Chief Financial Officer | Award / Grant | 97,500 | — | — | 205,500 | Apr 17, 2023 |
| Mayer Arie | — | Award / Grant | 30,000 | — | — | 56,809 | Apr 17, 2023 |
| Mayer Arie | — | Purchase | 5,009 | $2.22 | $11,120 | 23,009 | Apr 4, 2023 |
| KIDRON NADAV | President and CEO | Purchase | 26,000 | $2.04 | $53,040 | 126,000 | Mar 16, 2023 |
| KIDRON NADAV | President and CEO | Purchase | 100,000 | $2.01 | $201,000 | 100,000 | Mar 14, 2023 |
| Kidron Miriam | Chief Scientific Officer | Sale | 100,000 | $2.01 | $201,000 | 201,666 | Mar 14, 2023 |
| Rozov Yadin | — | Purchase | 20,000 | $1.96 | $39,200 | 36,500 | Mar 14, 2023 |
| Rabinowitz Michael | Chief Commercial Officer | Sale | 1,425 | $13.01 | $18,539 | 138,043 | Jan 3, 2023 |